US · Healthcare · Medical Instruments & Supplies
EPS came in at 0.47 against a street estimate of 0.30 — a beat of 56.7%.
with an average price target of $44.60.
MIXED Medline raised FY26 organic sales guidance to 9–10% on strong 12% Q2 growth, but cut EBITDA guidance citing Tracy fire, quality investments, and operational headwinds. Underlying margin pressure offsets robust top-line execution. Q2 2026 Acute care drives growth; non-acute held back by retail. International volume growth in Canada and Europe supports momentum. Analysts pressed on nature and permanence of operational investment costs, Middle East macro assumptions, and pathway to restore earnings leverage. Management clarified investments are intentional, growth-supporting, and partially reversible; emphasized disciplined cost savings and pricing optionality to recover margin over time. 2026-08-05…
Full summary in the app.
| Fund | Stake |
|---|---|
| The Carlyle Group Inc | 21.32% |
| H&F Corporate Investors X, Ltd. | 8.08% |
| Capital Research Global Investors | 4.56% |
| FMR Inc | 4.17% |
| Lone Pine Capital LLC | 2.39% |
| Amvescap Plc. | 2.39% |
| BlackRock Inc | 1.93% |
| Egerton Capital LLP | 1.88% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 MEDLINE INC. – FORM 10-Q SUMMARY FOR RETAIL INVESTORS Quarter Ended June 27, 2026 --- HEADLINE NUMBERS • Net sales (6 months): $15,037 million vs. | 2026-08-05 |
| Results announced · Q3 2026 MEDLINE INC. - Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 net sales: $7.7 billion, up 11.6% year-over-year • Q2 2026 net income: $139 milli | 2026-08-05 |
| Board / officer change · Q3 2026 MEDLINE INC. (MDLN) - 8-K SUMMARY HEADLINE NUMBERS • Company: Medline Inc., Delaware incorporated, trading on Nasdaq under ticker MDLN • Principal l | 2026-07-09 |
| Shareholder vote results · Q2 2026 MEDLINE INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Stockholders held on June 11, 2026 • Total shares voted (all director elections | 2026-06-12 |
| Material agreement · Q2 2026 MEDLINE INC. - 8-K SUMMARY (May 28, 2026) HEADLINE NUMBERS • Issued $1,250.0 million of 5.000% Senior Secured Notes due 2031 (2031 Notes) • Issued $ | 2026-06-02 |
| Quarterly report · Q1 2026 MEDLINE INC. - Q1 2026 10-Q SUMMARY FOR RETAIL INVESTORS --- HEADLINE NUMBERS • Net sales Q1 2026: $7,352 million (up from $6,644 million in Q1 202 | 2026-05-06 |
| Proxy statement · Q2 2026 MEDLINE INC. 2026 PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect 12 director nominees to one-year terms expiring in 202 | 2026-04-23 |
| Annual report FY2025 MEDLINE INC. - 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Company: Medline Inc., largest provider of medical-surgical (med-surg) products | 2026-02-25 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Medline Inc. Class A Common Stock — free to start.
Google PlayApp StoreData updated 2026-09-18.